1 – 10 of 34
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        An optimised Bcl-3 inhibitor for melanoma treatment
    
    - Contribution to journal › Article
 
- 
                        Mark
        Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
    
    - Contribution to journal › Article
 
- 
                        Mark
        Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
    
    - Contribution to journal › Scientific review
 
- 
                        Mark
        Editorial : Celebration of DNA Day
    
    - Contribution to journal › Debate/Note/Editorial
 
- 
                        Mark
        Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
    
    - Contribution to journal › Article
 
- 
                        Mark
        From master’s thesis to research publication : a mixed-methods study of medical student publishing and experiences with the publishing process
    
    - Contribution to journal › Article
 
- 
                        Mark
        Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Tetraploidization Increases the Motility and Invasiveness of Cancer Cells
    
    - Contribution to journal › Article
 
- 
                        Mark
        PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
    
    - Contribution to journal › Article
 
